Autopsy report · NCT04220411

A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)

“Due to the two AEs in Phase IIa study, recruiting was stopped for safety sake. The study was currently terminated.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 1 year 6 months before it stopped.
• 17 participants enrolled.
• Results were posted on the registry 1 year 6 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Arjil Pharmaceuticals LLC

Sponsor type

Industry

Conditions

Dermatitis, Atopic

Interventions

AR100DP1

Participants

17

Sites

1

Countries

Taiwan

Trials that died the same way

• Focus on Fibre Study
  “There were issues with recruitment so study was stopped” (71% match in meaning)
• Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
  “The study was stopped due to recruitment difficulties” (71% match in meaning)
• Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)
  “Study was stopped due to insufficient recruitment.” (69% match in meaning)
• Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
  “The study was terminated prematurely because of difficulty with recruiting.” (69% match in meaning)
• Study of Vascular Function Before vs After Smoking an E-cigarette as Compared to a Normal Cigarette
  “due to recruitment reasons the study was prematurely ended” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.